+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hemostats Market Size, Share & Trends Analysis Report by Type (Oxidized Regenerated Cellulose Based Hemostats), Formulation (Matrix & Gel Hemostats), Application (General Surgery), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 130 Pages
  • March 2024
  • Region: Global
  • Grand View Research
  • ID: 5950078
Description Jump to:
The global hemostats market size is anticipated to reach USD 4.24 billion by 2030, expanding at a CAGR of 6.76% from 2024 to 2030. This growth can be attributed to the increasing competition among market players and rising approvals for hemostats from various regulatory authorities, such as the Food and Drug Administration (FDA). Moreover, increasing adoption of minimally invasive procedures and significant improvements in healthcare infrastructure are propelling the demand for hemostatic agents. A rising number of surgeries is a significant driving factor of market growth.

For instance, according to the American Society of Plastic Surgeons (ASPS), there were 26.2 million surgical and minimally invasive cosmetic and reconstructive procedures performed in the United States in 2022. Furthermore, an increasing volume of orthopedic, cardiovascular, and hernia repair surgeries drives the demand for hemostats. Moreover, the market is witnessing a significant boost due to the rising prevalence of chronic diseases like arthritis and osteoporosis. These conditions often necessitate surgical procedures, and patients with these diseases may have a substantial risk of bleeding during surgeries.

Hemostatic agents play a pivotal role in managing this bleeding effectively, preventing complications like hematoma formation and extended surgery times. The rising aging population contributes to market growth. The geriatric population is more prone to specific health issues, often requiring surgical procedures for effective management. As per the data from the CDC, in the U.S. the population aged 65 years & older is projected to reach 98 million by 2060. This demographic shift implies a greater need for effective hemostatic agents to control post-surgical bleeding.

Hemostats Market Report Highlights

  • In 2023, the oxidized regenerated cellulose-based hemostats segment accounted for the largest market share. This can be attributed to the superior biocompatibility of these agents, which makes them well-tolerated by the body and reduces the likelihood of causing adverse reactions or tissue irritation
  • The matrix & gel hemostats segment dominated the market in 2023. Matrix & gel hemostats offer ease of use, efficient clotting & wound-sealing capabilities, and versatility, which make them a preferred choice in various medical applications
  • The orthopedic surgery segment led the market in 2023 due to the high frequency of orthopedic surgeries, such as knee and hip replacements, which often involve significant bleeding requiring effective hemostatic agents
  • The hospitals & clinics end-use segment dominated the market in 2023 due to the high volume of surgical procedures performed in these settings. Hospitals and clinics often require a wide variety of hemostatic agents to manage bleeding in various surgical procedures
  • North America held the largest revenue share in 2023 due to the presence of advanced healthcare infrastructure, major industry players, and high volume of surgical procedures performed in the U.S., especially in areas like orthopedics and cardiovascular surgeries


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemostats Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of chronic diseases
3.2.1.2. Rising geriatric population
3.2.1.3. Increasing number of surgeries
3.2.2. Market Restraint Analysis
3.2.2.1. Product recall & failure
3.3. Hemostats Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. Hemostats Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hemostats Market: Type Movement Analysis
4.3. Hemostats Market by Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Thrombin-based Hemostats
4.5.1. Thrombin-based Hemostat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Oxidized Regenerated Cellulose-based Hemostats
4.6.1. Oxidized Regenerated Cellulose-based Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Combination Hemostats
4.7.1. Combination Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Hemostats Market: Formulation Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Hemostats Market: Formulation Movement Analysis
5.3. Hemostats Market by Formulation Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Matrix and Gel Hemostats
5.5.1. Matrix and Gel Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Sponge Hemostats
5.6.1. Sponge Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Powder Hemostats
5.7.1. Powder Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Hemostats Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Hemostats Market: Application Movement Analysis
6.3. Hemostats Market by Application Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Orthopedic Surgery
6.5.1. Orthopedic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. General Surgery
6.6.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Neurological Surgery
6.7.1. Neurological Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Cardiovascular Surgery
6.8.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Hemostats Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Hemostats Market: End-use Movement Analysis
7.3. Hemostats Market by End-use Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Hospitals & Clinics
7.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Ambulatory Surgical Centers
7.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Casualty Care Centers
7.7.1. Casualty Care Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Others
7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Hemostats Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Regional Hemostats Market movement analysis
8.3. Hemostats Market: Regional Estimates & Trend Analysis by Type, Formulation, Application, & End-use
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. North America
8.5.1. North Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. U.S.
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement scenario
8.5.2.5. U.S. Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Canada
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement scenario
8.5.3.5. Canada Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.4. Europe
8.5.5. Europe Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.6. UK
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Reimbursement scenario
8.5.6.5. UK Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.7. Germany
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Reimbursement scenario
8.5.7.5. Germany Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.8. France
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Reimbursement scenario
8.5.8.5. France Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.9. Italy
8.5.9.1. Key Country Dynamics
8.5.9.2. Competitive Scenario
8.5.9.3. Regulatory Framework
8.5.9.4. Reimbursement scenario
8.5.9.5. Italy Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.10. Spain
8.5.10.1. Key Country Dynamics
8.5.10.2. Competitive Scenario
8.5.10.3. Regulatory Framework
8.5.10.4. Reimbursement scenario
8.5.10.5. Spain Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.11. Denmark
8.5.11.1. Key Country Dynamics
8.5.11.2. Competitive Scenario
8.5.11.3. Regulatory Framework
8.5.11.4. Reimbursement scenario
8.5.11.5. Denmark Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.12. Sweden
8.5.12.1. Key Country Dynamics
8.5.12.2. Competitive Scenario
8.5.12.3. Regulatory Framework
8.5.12.4. Reimbursement scenario
8.5.12.5. Sweden Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.13. Norway
8.5.13.1. Key Country Dynamics
8.5.13.2. Competitive Scenario
8.5.13.3. Regulatory Framework
8.5.13.4. Reimbursement scenario
8.5.13.5. Norway Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement scenario
8.6.2.5. Japan Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement scenario
8.6.3.5. China Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement scenario
8.6.4.5. India Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement scenario
8.6.5.5. South Korea Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.6. Australia
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Reimbursement scenario
8.6.6.5. Australia Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Reimbursement scenario
8.6.7.5. Thailand Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Reimbursement scenario
8.7.2.5. Brazil Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.3. Mexico
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Reimbursement scenario
8.7.3.5. Mexico Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.4. Argentina
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. Reimbursement scenario
8.7.4.5. Argentina Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Reimbursement scenario
8.8.2.5. South Africa Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Reimbursement scenario
8.8.3.5. Saudi Arabia Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. Reimbursement scenario
8.8.4.5. UAE Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competitive Scenario
8.8.5.3. Regulatory Framework
8.8.5.4. Reimbursement scenario
8.8.5.5. Kuwait Hemostats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. Johnson & Johnson
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Pfizer
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. B. Braun Melsungen AG
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Integra LifeSciences Corporation
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. CryoLife Inc (Artivion)
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Becton Dickinson and Company
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Medtronic
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Baxter
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global hemostats market, by type, 2018 - 2030 (USD Million)
Table 4. Global hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 5. Global hemostats market, by application, 2018 - 2030 (USD Million)
Table 6. Global hemostats market, by end-use, (USD million) 2018 - 2030
Table 7. North America hemostats market, by region, 2018 - 2030 (USD Million)
Table 8. North America hemostats market, by type, 2018 - 2030 (USD Million)
Table 9. North America hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 10. North America hemostats market, by application, 2018 - 2030 (USD Million)
Table 11. North America hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 12. U.S. hemostats market, by type, 2018 - 2030 (USD Million)
Table 13. U.S. hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 14. U.S. hemostats market, by application, 2018 - 2030 (USD Million)
Table 15. U.S. hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 16. Canada hemostats market, by type, 2018 - 2030 (USD Million)
Table 17. Canada hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 18. Canada hemostats market, by application, 2018 - 2030 (USD Million)
Table 19. Canada hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 20. Europe hemostats market, by country, 2018 - 2030 (USD Million)
Table 21. Europe hemostats market, by type, 2018 - 2030 (USD Million)
Table 22. Europe hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 23. Europe hemostats market, by application, 2018 - 2030 (USD Million)
Table 24. Europe hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 25. UK hemostats market, by type, 2018 - 2030 (USD Million)
Table 26. UK hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 27. UK hemostats market, by application, 2018 - 2030 (USD Million)
Table 28. UK hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 29. Germany hemostats market, by type, 2018 - 2030 (USD Million)
Table 30. Germany hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 31. Germany hemostats market, by application, 2018 - 2030 (USD Million)
Table 32. Germany hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 33. France hemostats market, by type, 2018 - 2030 (USD Million)
Table 34. France hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 35. France hemostats market, by application, 2018 - 2030 (USD Million)
Table 36. France hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 37. Italy hemostats market, by type, 2018 - 2030 (USD Million)
Table 38. Italy hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 39. Italy hemostats market, by application, 2018 - 2030 (USD Million)
Table 40. Italy hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 41. Spain hemostats market, by type, 2018 - 2030 (USD Million)
Table 42. Spain hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 43. Spain hemostats market, by application, 2018 - 2030 (USD Million)
Table 44. Spain hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 45. Norway hemostats market, by type, 2018 - 2030 (USD Million)
Table 46. Norway hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 47. Norway hemostats market, by application, 2018 - 2030 (USD Million)
Table 48. Norway hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 49. Sweden hemostats market, by type, 2018 - 2030 (USD Million)
Table 50. Sweden hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 51. Sweden hemostats market, by application, 2018 - 2030 (USD Million)
Table 52. Sweden hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 53. Denmark hemostats market, by type, 2018 - 2030 (USD Million)
Table 54. Denmark hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 55. Denmark hemostats market, by application, 2018 - 2030 (USD Million)
Table 56. Denmark hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 57. Asia Pacific hemostats market, by country, 2018 - 2030 (USD Million)
Table 58. Asia Pacific hemostats market, by type, 2018 - 2030 (USD Million)
Table 59. Asia Pacific hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 60. Asia Pacific hemostats market, by application, 2018 - 2030 (USD Million)
Table 61. Asia Pacific hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 62. Japan hemostats market, by type, 2018 - 2030 (USD Million)
Table 63. Japan hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 64. Japan hemostats market, by application, 2018 - 2030 (USD Million)
Table 65. Japan hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 66. China hemostats market, by type, 2018 - 2030 (USD Million)
Table 67. China hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 68. China hemostats market, by application, 2018 - 2030 (USD Million)
Table 69. China hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 70. India hemostats market, by type, 2018 - 2030 (USD Million)
Table 71. India hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 72. India hemostats market, by application, 2018 - 2030 (USD Million)
Table 73. India hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 74. Australia hemostats market, by type, 2018 - 2030 (USD Million)
Table 75. Australia hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 76. Australia hemostats market, by application, 2018 - 2030 (USD Million)
Table 77. Australia hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 78. South Korea hemostats market, by type, 2018 - 2030 (USD Million)
Table 79. South Korea hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 80. South Korea hemostats market, by application, 2018 - 2030 (USD Million)
Table 81. South Korea hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 82. Thailand hemostats market, by type, 2018 - 2030 (USD Million)
Table 83. Thailand hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 84. Thailand hemostats market, by application, 2018 - 2030 (USD Million)
Table 85. Thailand hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 86. Latin America hemostats market, by country, 2018 - 2030 (USD Million)
Table 87. Latin America hemostats market, by type, 2018 - 2030 (USD Million)
Table 88. Latin America hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 89. Latin America hemostats market, by application, 2018 - 2030 (USD Million)
Table 90. Latin America hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 91. Brazil hemostats market, by type, 2018 - 2030 (USD Million)
Table 92. Brazil hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 93. Brazil hemostats market, by application, 2018 - 2030 (USD Million)
Table 94. Brazil hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 95. Mexico hemostats market, by type, 2018 - 2030 (USD Million)
Table 96. Mexico hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 97. Mexico hemostats market, by application, 2018 - 2030 (USD Million)
Table 98. Mexico hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 99. Argentina hemostats market, by type, 2018 - 2030 (USD Million)
Table 100. Argentina hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 101. Argentina hemostats market, by application, 2018 - 2030 (USD Million)
Table 102. Argentina hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 103. Middle East & Africa hemostats market, by country, 2018 - 2030 (USD Million)
Table 104. Middle East & Africa hemostats market, by type, 2018 - 2030 (USD Million)
Table 105. Middle East & Africa hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 106. Middle East & Africa hemostats market, by application, 2018 - 2030 (USD Million)
Table 107. Middle East & Africa hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 108. South Africa hemostats market, by type, 2018 - 2030 (USD Million)
Table 109. South Africa hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 110. South Africa hemostats market, by application, 2018 - 2030 (USD Million)
Table 111. South Africa hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 112. Saudi Arabia hemostats market, by type, 2018 - 2030 (USD Million)
Table 113. Saudi Arabia hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 114. Saudi Arabia hemostats market, by application, 2018 - 2030 (USD Million)
Table 115. Saudi Arabia hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 116. UAE hemostats market, by type, 2018 - 2030 (USD Million)
Table 117. UAE hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 118. UAE hemostats market, by application, 2018 - 2030 (USD Million)
Table 119. UAE hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 120. Kuwait hemostats market, by type, 2018 - 2030 (USD Million)
Table 121. Kuwait hemostats market, by formulation, 2018 - 2030 (USD Million)
Table 122. Kuwait hemostats market, by application, 2018 - 2030 (USD Million)
Table 123. Kuwait hemostats market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Hemostats market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Hemostats market, type outlook key takeaways (USD Million)
Fig. 12 Hemostats market: type movement analysis 2023 & 2030 (USD Million)
Fig. 13 Thrombin based hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Oxidized regenerated cellulose-based hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Combination hemostat market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Hemostats market: formulation movement analysis 2023 & 2030 (USD Million)
Fig. 18 Matrix and gel hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Sponge hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Powder hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Hemostats market: application movement analysis 2023 & 2030 (USD Million)
Fig. 23 Orthopedic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 General surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Neurological surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Cardiovascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Hemostats market, end use outlook key takeaways (USD Million)
Fig. 29 Hemostats market: end use movement analysis 2023 & 2030 (USD Million)
Fig. 30 Hospitals & Clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Casualty care centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Hemostats market: Regional key takeaways (USD Million)
Fig. 35 Hemostats market: regional outlook, 2023 & 2030 (USD Million)
Fig. 36 North America hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Europe hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 UK hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Germany hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 France hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Spain hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Italy hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Sweden hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Norway hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Denmark hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 China hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Japan hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 India hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Korea hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Australia hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Thailand hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Latin America hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Brazil hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Mexico hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Argentina hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 South Africa hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 UAE hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Kuwait hemostats market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 List of key emerging company’s/technology disruptors/innovators

Companies Mentioned

  • Johnson & Johnson
  • Pfizer
  • B. Braun Melsungen AG
  • Integra LifeSciences Corporation
  • CryoLife Inc (Artivion)
  • Becton Dickinson and Company
  • Medtronic
  • Baxter

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages130
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.24 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Global Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Forecast 2024-2030 - Product Image

Global Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Global Topical Hemostat Market by Product (Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application, End-Use - Forecast 2024-2030 - Product Image

Global Topical Hemostat Market by Product (Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application, End-Use - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Global Hemostats Market by Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen), Formulation (Matrix & Gel, Sheet & Pad, Sponge, Powder), Application (Orthopedic, Neurological, Cardiovascular Surgery), Region - Forecast to 2028 - Product Image

Global Hemostats Market by Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen), Formulation (Matrix & Gel, Sheet & Pad, Sponge, Powder), Application (Orthopedic, Neurological, Cardiovascular Surgery), Region - Forecast to 2028

  • Report
  • 223 Pages
  • Global
From
Hemostats Global Market Report 2024 - Product Image

Hemostats Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Hemostats Market Report by Product, Application, Formulation, and Region 2024-2032 - Product Image

Hemostats Market Report by Product, Application, Formulation, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.